When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

$14.51 (4.01%)

Volume: 665.019k

Closed: Aug 05, 2022

Hollow Logo Score: 0.000

FibroGen Stock Forecast

$14.51 (4.01%)

Volume: 665.019k

Closed: Aug 05, 2022

Score Hollow Logo 0.000

FGEN Price Targets and Analyst Ratings NASDAQ:FGEN

FGEN Forecast. What You Should Know.

FGEN Historical Ratings and Targets

Unlock All Premium Features! Go Premium! Only $19.90/Month

Unlock the Top 5 candidates in every list
Unlock full Ultimate List Builder
Golden Star lists & Auto Portfolios
Possible Runners & Moving Average lists
Ad-free browsing
Save data in PDF

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... Read more


StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE